CRISIL reaffirms rating assigned to Sandu Pharmaceutical’s bank facilities

05 Mar 2018 Evaluate

The credit rating agency, CRISIL has reaffirmed ‘BB/stable’ rating assigned to Sandu Pharmaceutical’s long term bank facilities. Total bank loan facilities rated are worth Rs 13.35 crore.

Sandu Pharmaceuticals Ltd is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

Sandu Pharmaceutical Share Price

37.90 -0.84 (-2.17%)
31-Dec-2025 12:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1268.25
Cipla 1502.40
Zydus Lifesciences 913.30
Lupin 2105.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×